Evidence map›Paper›PMID 33182823›Full record

ArticleNanomaterials (Basel, Switzerland)2020

PNA-Based Graphene Oxide/Porous Silicon Hybrid Biosensor: Towards a Label-Free Optical Assay for Brugada Syndrome.

Rosalba Moretta, Monica Terracciano, Nicola Borbone, Giorgia Oliviero, Chiara Schiattarella, Gennaro Piccialli, Andrea Patrizia Falanga, Maria Marzano, Principia Dardano, Luca De Stefano and 1 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Exploring the DNAHeliyon · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rosalba MorettaInstitute of Applied Sciences and Intelligent Systems, National Research Council, 80131 Naples, Italy.
Monica TerraccianoDepartment of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0001-6367-2419
Nicola BorboneDepartment of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0003-0216-9814
Giorgia OlivieroDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.
Chiara SchiattarellaDepartment of Physics "E. Pancini", University of Naples Federico II, 80126 Naples, Italy.
Gennaro PiccialliDepartment of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.
Andrea Patrizia FalangaDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy.
Maria MarzanoInstitute of Crystallography, National Research Council, 70126 Bari, Italy.
Principia DardanoInstitute of Applied Sciences and Intelligent Systems, National Research Council, 80131 Naples, Italy.
Luca De StefanoInstitute of Applied Sciences and Intelligent Systems, National Research Council, 80131 Naples, Italy.ORCID 0000-0002-9442-4175
Ilaria ReaInstitute of Applied Sciences and Intelligent Systems, National Research Council, 80131 Naples, Italy.ORCID 0000-0003-0568-9911

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide nucleic acid (PNA) is a synthetic DNA mimic that outperforms the properties of traditional oligonucleotides (ONs). On account of its outstanding features, such as remarkable binding affinity towards complementary DNA or RNA as well as high thermal and chemical stability, PNA has been proposed as a valuable alternative to the ON probe in gene-sensor design. In this study, a hybrid transducer made-up of graphene oxide (GO) nano-sheets covalently grafted onto a porous silicon (PSi) matrix has been investigated for the early detection of a genetic cardiac disorder, the Brugada syndrome (BS). A functionalization strategy towards the realization of a potential PNA-based device is described. A PNA, able to detect the SCN5A gene associated with the BS, has been properly synthesized and used as a bioprobe for the realization of a proof-of-concept label-free optical PNA-biosensor. PSi reflectance and GO photoluminescence signals were simultaneously exploited for the monitoring of the device functionalization and response.

Indexed as

Brugada syndromegraphene oxidehybrid devicelabel-free optical biosensorpeptide nucleic acid-PNAporous silicon

Identifiers

PMID33182823
PMCPMC7697640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.